The first US homeopathic firm to receive a warning since the Food and Drug Administration published a final guidance on regulating Rx and OTC products in the category likely would have attracted the agency’s scrutiny independent of the guidance.
The FDA Office of Regulatory Affairs’ Division of Pharmaceutical Quality Operations IV advised Green Pharmaceuticals Inc
The agency said its testing of a batch of SnoreStop NasoSpray showed the product is adulterated under FDA regulations because “it consists in whole or in